Mark Whittaker
Impact in
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms
- Oncology top 2%
- Peptidase Inhibition and Analysis
Papers in
-
- Chemical Synthesis and Analysis 11
- Receptor Mechanisms and Signaling 9
- Co-authors
- Christopher D. Floyd (7 shared papers)Peter de Nully Brown (6 shared papers)A. J. H. Gearing (4 shared papers)R. Paul Beckett (14 shared papers)Leon Black (5 shared papers)Heather Tye (12 shared papers)Alan H. Drummond (7 shared papers)Osamu Ichihara (7 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (14 papers)Tetrahedron Letters (11 papers)Cancer Research (6 papers)Advances in Cement Research (4 papers)Combinatorial Chemistry & High Throughput Screening (3 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Mark Whittaker
107 papers receiving 4.1k citations
Mark Whittaker's Hit Papers
Peers
Comparison fields: 5 of 149
- Cancer Research 923
- Oncology 1.2k
- Organic Chemistry 1.3k
- Molecular Biology 1.8k
- Computational Theory and Mathematics 376
Countries citing papers authored by Mark Whittaker
This map shows the geographic impact of Mark Whittaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Whittaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Whittaker more than expected).
Fields of papers citing papers by Mark Whittaker
This network shows the impact of papers produced by Mark Whittaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Whittaker. The network helps show where Mark Whittaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Whittaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors Hit paper breakdown → | 1999 | 854 |
| 2 | 1996 | 231 | |
| 3 | 2001 | 189 | |
| 4 | 1999 | 180 | |
| 5 | 2014 | 156 | |
| 6 | 2006 | 122 | |
| 7 | 1998 | 116 | |
| 8 | 2015 | 113 | |
| 9 | 2011 | 97 | |
| 10 | 1996 | 88 | |
| 11 | 2003 | 87 | |
| 12 | 2008 | 80 | |
| 13 | 2011 | 70 | |
| 14 | 2013 | 68 | |
| 15 | 1994 | 66 | |
| 16 | 2012 | 62 | |
| 17 | 2004 | 59 | |
| 18 | 2016 | 58 | |
| 19 | 2001 | 58 | |
| 20 | 2010 | 54 |
About Mark Whittaker
Mark Whittaker is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cancer Research and Inorganic Chemistry, having authored 107 papers that have together received 4.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (16 papers), Protease and Inhibitor Mechanisms (14 papers), Chemical Synthesis and Analysis (11 papers), Asymmetric Hydrogenation and Catalysis (10 papers), Concrete and Cement Materials Research (9 papers), Receptor Mechanisms and Signaling (9 papers), Computational Drug Discovery Methods (9 papers) and Metal-Catalyzed Oxygenation Mechanisms (9 papers). The work is most often cited by research in Cancer Research (923 citations), Oncology (1.2k citations), Organic Chemistry (1.3k citations), Molecular Biology (1.8k citations) and Computational Theory and Mathematics (376 citations). Mark Whittaker has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Christopher D. Floyd, Peter de Nully Brown, A. J. H. Gearing, R. Paul Beckett, Leon Black, Heather Tye, Alan H. Drummond, Osamu Ichihara, Thomas Hesterkamp and Richard Law. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Cancer Research, Advances in Cement Research and Combinatorial Chemistry & High Throughput Screening.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.